Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Children who are deaf or hard of hearing may experience higher rates of adverse childhood experiences (ACEs) than their ...

The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...

Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

Multi-year wins underscore sustained specialty-first innovation, workflow depth, and revenue-cycle performance at scale TAMPA, FLORIDA / ACCESS Newswire / January 15, 2026 / ModMed has again earned ...

Even when tech professionals believe they are likely to be caught, many can still be tempted into violating health privacy ...

Muse Treatment Alcohol & Drug Rehab Los Angeles has published a new educational resource that explains how opioid receptors ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated ...

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Clinical Trials ...

ModMed, Epic, NextGen Healthcare, Netsmart, athenahealth, and Specialty Category Innovators Lead Black Book's 2026 Ambulatory EHR Rankings NEW YORK CITY, NEW YORK / ACCESS Newswire / January 15, 2026 ...